Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Go back to Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: KYNB) Delayed: 6.70 --0 (-0%)
Previous Close $6.70    52 Week High
Open $6.70    52 Week Low
Day High $6.70    P/E N/A 
Day Low $6.70    EPS
Volume 11